Pfizer to pump $600 million in additional funding into biotech startups

Pfizer Inc. is looking to deploy millions into biotech startups. The New York-based pharmaceutical giant (NYSE: PFE) unveiled plans Wednesday to invest $600 million into emerging growth companies through its venture capital arm, Pfizer Ventures. The move likely will include a hiring spree, as Pfizer looks to expand its team across several areas of venture capi tal investing, including business development, drug discovery and clinical development. Pfizer Vice President Barbara Dalton praised the…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news